Full Schedule

8:00 AM - 7:00 PM ET

Registration

9:00 AM - 10:30 AM ET

Independent CE Satellite Symposium:
Oncolytic Therapy for Melanoma: Hands-On Training

Separate Registration Required

CE/CME: 1.50 credits/hours

11:00 AM - 12:30 PM ET

Independent CE Satellite Symposium (Repeat of 9:00 am Session):
Oncolytic Therapy for Melanoma: Hands-On Training

Separate Registration Required

CE/CME: 1.50 credits/hours

11:00 AM - 3:00 PM ET

Braindate

1:00 PM - 3:00 PM ET

Pre-Conference Session
Advances in Cancer Immunotherapy (ACI): Managing Multi-Organ Toxicities Associated With Cell Therapies and Immune Checkpoint Inhibitors
Collaboration between Society for Immunotherapy in Cancer (SITC) & APSHO

Ticketed Event - Included w. Registration

Panel Session Speaker: – Yale Comprehensive Cancer Center, Yale New Haven Hospital & Yale University

Panel Session Speaker: – MD Anderson Cancer Center

Panel Session Speaker: – Mayo Clinic

Panel Session Speaker: – Abramson Cancer Center, Hospital of the University of Pennsylvania

CE/CME: 2.00 credits/hours

1:00 PM - 3:00 PM ET

Pre-Conference Workshop: Hands-On Procedure Training
(Bone Marrow Aspiration, Lumbar Puncture, and Ommaya Reservoir Access)

Speaker: – Massey Comprehensive Cancer Center, Virginia Commonwealth University

Speaker: – Texas Oncology

Speaker: – Transitional Healthcare of America

CE/CME: 2.00 credits/hours

2:00 PM - 3:00 PM ET

Independent CE Satellite Symposium: Non-Small Cell Lung Cancer: Updates on Molecular Diagnostics, Targeted Treatment, and Adverse Event Management for Optimized Patient Outcomes

CE/CME: 0.75

2:45 PM - 3:30 PM ET

Refreshment Break

3:00 PM - 4:00 PM ET

Non-CE Satellite Symposium: Evolving Strategies for Locally Advanced or Metastatic EGFR-mutated NSCLC and HR+/HER2– (IHC 0, IHC 1+, IHC 2+/ISH–) mBC
AstraZeneca

3:00 PM - 4:00 PM ET

Non-CE Satellite Symposium: Partnering to Deliver Continuity of Care with Elrexfio (A BCMA-Directed Bispecific Immunotherapy for Certain Adult Patients With Relapsed or Refractory Multiple Myeloma).
Pfizer, Inc.

3:00 PM - 4:00 PM ET

Non-CE Satellite Symposium: Review of Evidence-Based Data for an Antibody-Drug Conjugate in Combination with a PD-1 Inhibitor for 1L LA/MUC
Astellas Pharma & Pfizer Oncology

4:00 PM - 6:00 PM ET

Pre-Conference Seminar: Addressing Psychological Burdens Throughout the Continuum of Care

Speaker: – Harvard Medical School

CE/CME: 2.00 credits/hours

4:00 PM - 6:00 PM ET

Pre-Conference Workshop: Hands-On Procedure Training
(Bone Marrow Aspiration, Lumbar Puncture, and Ommaya Reservoir Access)

(Repeat of 1:00 pm Session)

Speaker: – Massey Comprehensive Cancer Center, Virginia Commonwealth University

Speaker: – Texas Oncology

Speaker: – Transitional Healthcare of America

CE/CME: 2.00 credits/hours

5:00 PM - 5:45 PM ET

APSHO Annual Member Meeting

6:00 PM - 7:00 PM ET

Rare Disease Reception: Systemic Mastocytosis
Supported by Blueprint Medicines

6:00 PM - 7:00 PM ET

Rare Disease Reception: Uveal Melanoma
Supported by Immunocore

7:15 PM - 9:00 PM ET

Welcome Reception

6:30 AM - 5:30 PM ET

Registration

7:00 AM - 8:15 AM ET

Breakfast Activity/Non-CE Satellite Symposium: A Treatment Option for Adult Patients With Locally Advanced or Metastatic Urothelial Cancer
Merck & Co., Inc.

7:00 AM - 8:15 AM ET

Breakfast Activity/Non-CE Satellite Symposium: Reducing access barriers: New FDA label updates on cell therapy post-treatment monitoring requirements
Bristol Myers Squibb

7:00 AM - 8:15 AM ET

Breakfast Activity/Non-CE Satellite Symposium: Supporting Patients With HR+/HER2- mBC Throughout Their Treatment Journey
Pfizer, Inc.

7:00 AM - 8:15 AM ET

Breakfast Activity: Non-CE Satellite Symposium

7:00 AM - 8:20 AM ET

Exhibit Hall Open &
Continental Breakfast

8:30 AM - 8:35 AM ET

Welcome & Opening Remarks

Speaker: – Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital

Livestream

8:30 AM - 9:45 AM ET

The Power of a Unified Voice: Optimizing the AP Role Through Society Collaborations

Moderator: – Advanced Practitioner Society for Hematology and Oncology (APSHO)

Panelist: – Montefiore Medical Center/ Association of Cancer Care Centers (ACCC)

Panelist: – Association of PAs in Oncology (APAO)

Panelist: – Hematology/Oncology Pharmacy Association (HOPA)

Panelist: – Oncology Nursing Society (ONS)

Livestream

CE/CME: 1.25 credits/hours

9:45 AM - 4:30 PM ET

Braindate

9:55 AM - 10:55 AM ET

A Team-Based Approach to the Management of Acute and Late Radiation Side Effects

Speaker: – Penn State Health

CE/CME: 1.00 credits/hours

9:55 AM - 10:55 AM ET

Navigating Relapsed/Refractory Multiple Myeloma: Evidence-Based Approaches in a Changing Landscape

Speaker: – Mayo Clinic College of Medicine and Science

Speaker: – Mayo Clinic

CE/CME: 1.00 credits/hours

9:55 AM - 10:55 AM ET

New Drug Updates in Solid Tumors

Speaker: – UNC Health

Livestream

CE/CME: 1.00 credits/hours

11:00 AM - 11:30 AM ET

APSHO Meet & Greet
Awards & Recognition Committee

11:00 AM - 12:00 PM ET

Exhibit Hall Open &
Refreshment Break

11:05 AM - 11:35 AM ET

Exhibit Hall Presentation Theater

11:05 AM - 11:35 AM ET

Exhibit Hall Presentation Theater: Exploring the Role of c-Met Protein Overexpression in the NSCLC Treatment Landscape
AbbVie

11:05 AM - 11:50 AM ET

Exhibit Hall Presentation Theater: Offering TRODELVY for Appropriate Patients With Pretreated HR+/HER2- mBC and mTNBC
Gilead and Kite Oncology

11:05 AM - 12:00 PM ET

Moderated Posters: Clinical Posters, Industry Encore Posters, and APSHO Patient Advocacy Posters

11:30 AM - 12:00 PM ET

APSHO Meet & Greet:
Communications Committee

12:10 PM - 12:55 PM ET

Navigating p16-Positive Oropharyngeal Cancer: A Multidisciplinary Patient-Centered Approach

Speaker: – Texas Oncology Baylor Sammons Cancer Center

Speaker: – The University of Texas MD Anderson Cancer Center

CE/CME: 0.75 credits/hours

12:10 PM - 12:55 PM ET

Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer

Speaker: – Allegheny Health Network Cancer Institute

Speaker: – Allegheny Health Network

Livestream

CE/CME: 0.75 credits/hours

12:10 PM - 12:55 PM ET

The Lowdown on Low Counts: Navigating Complex Cases in Therapy-Related Cytopenias

Speaker: – University of California, San Francisco

CE/CME: 0.75 credits/hours

1:00 PM - 2:20 PM ET

Exhibit Hall Open &
Lunch

1:00 PM - 2:20 PM ET

Lunch Activity: Non-CE Satellite Symposium

1:00 PM - 2:20 PM ET

Lunch Activity/Non-CE Satellite Symposium: A 2L Treatment Option for HR+/HER2− aBC or mBC With PIK3CA, AKT1, or PTEN Alterations Following Progression on or After ET ± CDK4/6i
AstraZeneca

1:00 PM - 2:20 PM ET

Lunch Activity/Non-CE Satellite Symposium: A Treatment Option for Adults with Certain R/R DLBCL After ≥2 Prior Lines of Systemic Therapy
Pfizer, Inc.

1:00 PM - 2:20 PM ET

Lunch Activity/Non-CE Satellite Symposium: Addressing Real-World Clinical Evidence in Polycythemia Vera and Myelofibrosis: Subtitle: A Case-Based Discussion on Clinical Decision Making
Incyte Corporation

1:00 PM - 2:20 PM ET

Lunch Activity/Non-CE Satellite Symposium: Alternative Routes of Administration: Advancing Oncology Care with Subcutaneous Immunotherapy
Bristol Myers Squibb

1:30 PM - 2:00 PM ET

APSHO Meet & Greet:
Diversity, Equity, & Inclusion (DEI) Committee

2:00 PM - 2:30 PM ET

APSHO Meet & Greet:
Mentor Match Meet Up

2:30 PM - 3:30 PM ET

KEYNOTE ADDRESS
Clinician and Kin: United in Care with the Family Caregiver

Speaker: – JenniferAOBrien.com

Livestream

CE/CME: 1.00 credits/hours

3:30 PM - 4:00 PM ET

APSHO Meet & Greet
Surgical Oncology Committee

3:35 PM - 4:35 PM ET

Exhibit Hall Open &
Refreshment Break

3:40 PM - 4:10 PM ET

Exhibit Hall Presentation Theater: Head to Head Overall Survival in mCSPC: A Review of Real World Evidence.
Johnson & Johnson

4:00 PM - 4:30 PM ET

APSHO Meet & Greet
APSHO Board of Directors

4:45 PM - 5:45 PM ET

Multidisciplinary Management of Spinal Metastases: Integrating Surgery and Radiation Therapy

Speaker: – Dana-Farber Brigham and Women's Cancer Center

Speaker: – OrthoIndy

CE/CME: 1.00 credits/hours

4:45 PM - 5:45 PM ET

Sequencing Therapies in Non-Hodgkin Lymphomas

Speaker: – UNC Health Care/ Division of Hematology

Speaker: – Alaska Native Medical Center

Livestream

CE/CME: 1.00 credits/hours

4:45 PM - 6:00 PM ET

Oral Poster Presentations (Part 1)

CE/CME: 1.25 credits/hours

6:00 PM - 7:00 PM ET

Independent CE Satellite Symposium: Relapsed/Refractory Multiple Myeloma: Evidence-Based Guidelines and Essential Strategies for Optimized Treatment Selection and Sequencing

CE/CME: 0.75

7:30 PM - 9:00 PM ET

Independent CE Dinner Satellite Symposium: Managing HER2 and TROP2 ADC Adverse Events: Advanced Practice Providers Case Discussions Highlighting the Critical Roles in Patient Care

CE/CME: 1.00

6:30 AM - 5:30 PM ET

Registration

7:00 AM - 8:15 AM ET

Breakfast Activity/Non-CE Satellite Symposium: A Treatment Option for certain patients with Hepatocellular Carcinoma
Bristol Myers Squibb

7:00 AM - 8:15 AM ET

Exhibit Hall Open &
Continental Breakfast

7:00 AM - 8:15 PM ET

Breakfast Activity/Non-CE Satellite Symposium: AYVAKIT, The only approved treatment for Indolent Systemic Mastocytosis and Advanced Systemic Mastocytosis
Blueprint Medicines

8:20 AM - 8:30 AM ET

Opening Remarks & APSHO FAPO Recognition Presentation

Livestream

8:30 AM - 8:40 AM ET

The Annual Mary Pazdur Award Presentation

Livestream

8:45 AM - 9:15 AM ET

The Mary Pazdur Award Recipient Lecture

Livestream

CE/CME: 0.50 credits/hours

9:25 AM - 10:25 AM ET

Interpreting Post-Therapeutic Diagnostic Studies

Speaker: – University of North Carolina at Chapel Hill

Livestream

CE/CME: 1.00 credits/hours

9:25 AM - 10:25 AM ET

Rebuilding Form and Function: Innovations in Reconstructive Care for the Patient With Cancer

Speaker: – The James, Ohio State University Comprehensive Cancer Center

CE/CME: 1.00 credits/hours

9:25 AM - 10:25 AM ET

Therapeutic Advances in Metastatic Melanoma: TILs, ImmTACs, and Targeted Therapies

Speaker: – MGB Cancer Center

Speaker: – Mass General Cancer Center

Livestream

CE/CME: 1.00 credits/hours

9:45 AM - 4:30 PM ET

Braindate

10:30 AM - 11:30 AM ET

Exhibit Hall Open &
Refreshment Break

10:30 AM - 11:30 AM ET

Moderated Posters: Clinical Posters, Industry Encore Posters, and APSHO Patient Advocacy Posters

10:35 AM - 11:05 AM ET

Exhibit Hall Presentation Theater: EMERALD Study Update: Safety and Efficacy Data in Patients with ER+/HER2-, ESR1-mutated Metastatic Breast Cancer, including Subgroup Analyses
Stemline, a Menarini Group Company

10:35 AM - 11:05 AM ET

Exhibit Hall Presentation Theater: The Future of Endocrine Therapy Management: Harnessing Genomics for Better Outcomes
Agendia

11:00 AM - 11:30 AM ET

APSHO Meet & Greet
Professional & Leadership Development (PD&L) Committee

11:40 AM - 12:40 PM ET

Advances and Controversies in the Surgical Management of Colorectal Liver Metastases

Speaker: – UPMC Liver Cancer Center

Speaker: – University of Texas MD Anderson Cancer Center

CE/CME: 1.00 credits/hours

11:40 AM - 12:40 PM ET

Evidence-Based Exercise and Diet Strategies Across the Continuum of Cancer Care

Speaker: – Dana-Farber Cancer Institute

Livestream

CE/CME: 1.00 credits/hours

11:40 AM - 12:40 PM ET

Latest Clinical Evidence in Small Cell Lung Cancer Treatment

Speaker: – Dana-Farber Cancer Institute

Livestream

CE/CME: 1.00 credits/hours

12:45 PM - 2:00 PM ET

Exhibit Hall Open &
Lunch

12:45 PM - 2:00 PM ET

Lunch Activity/Non-CE Satellite Symposium: An Exelixis Clinical Presentation on CABOMETYX® (cabozantinib)
Exelixis

12:45 PM - 2:00 PM ET

Lunch Activity/Non-CE Satellite Symposium: Biomarker-Directed Treatment Options for ALK-Positive or BRAF V600E–Mutated Metastatic NSCLC
Pfizer, Inc.

12:45 PM - 2:00 PM ET

Lunch Activity/Non-CE Satellite Symposium: Myelofibrosis and Strategies for Disease Management: Key Considerations for Patient Care
GSK

1:00 PM - 1:30 PM ET

APSHO Meet & Greet
Membership Committee

7:00 AM - 8:15 AM ET

Breakfast Activity/Non-CE Satellite Symposium: A Fixed- Duration Treatment Option for 3L+ Diffuse Large B-Cell Lymphoma
Genentech

7:00 AM - 8:15 AM ET

Breakfast Activity/Non-CE Satellite Symposium: Treatment Options for Appropriate Patients With Certain Types of Advanced Gynecologic Cancers
Merck & Co., Inc.

1:30 PM - 2:00 PM ET

APSHO Meet & Greet
Education Committee

2:05 PM - 2:50 PM ET

Management of Myelodysplastic Syndromes: Emerging Therapies and Evidence-Based Practice

Speaker: – Vanderbilt University Medical Center

Livestream

CE/CME: 0.75 credits/hours

2:05 PM - 2:50 PM ET

Targeting More Than Tumors: Applying Pharmacogenomics to Oncology Practice

Speaker:

CE/CME: 0.75 credits/hours

2:05 PM - 2:50 PM ET

The Role of Radiation Therapy for Oligometastatic Lung Cancer

Speaker: – RUSH MD Anderson Cancer Center

CE/CME: 0.75 credits/hours

3:00 PM - 3:30 PM ET

APSHO Meet & Greet
Research & Quality Improvement (RQI) Committee

3:00 PM - 4:15 PM ET

Exhibit Hall Open &
Refreshment Break

3:05 PM - 3:50 PM ET

Exhibit Hall Presentation Theater: Living with Advanced NSCLC*: A Patient’s Treatment Journey
Regeneron Pharmaceuticals

3:05 PM - 3:35 PM ET

3:05 PM - 3:50 PM ET

Exhibit Hall Presentation Theater: Exploring BCL-2i-based Time-Limited Regimens Throughout the CLL Treatment Journey
AbbVie

3:30 PM - 4:00 PM ET

APSHO Meet & Greet:
Radiation Oncology Committee

4:25 PM - 5:25 PM ET

Beyond the Usual Suspects: Differentiating and Managing Complex Soft-Tissue Tumors

Speaker: – Washington University Siteman Cancer Center

Speaker: – Siteman Cancer Center at Barnes Jewish Hospital and Washington University School of Medicine

CE/CME: 1.00 credits/hours

4:25 PM - 5:25 PM ET

Elevating Your Voice: Empowering Advanced Practitioners in the Insurance Peer-to-Peer Process

Speaker: – The University of Texas MD Anderson Cancer Center

CE/CME: 1.00 credits/hours

4:25 PM - 5:40 PM ET

New-to-Oncology Roundtables

CE/CME: 1.25 credits/hours

5:00 PM - 7:30 PM ET

Independent CE Satellite Symposium: Advancing Care in Genitourinary Cancers: Integrating Targeted Therapies for Metastatic Urothelial Carcinoma and Advanced Prostate Cancer

CE/CME: 1.50

6:30 AM - 12:00 PM ET

Registration

7:00 AM - 9:00 AM ET

Continental Breakfast

7:15 AM - 8:30 AM ET

Oral Poster Presentations (Part 2)

CE/CME: 1.25 credits/hours

8:00 AM - 9:15 AM ET

Breakfast Activity/Non-CE Satellite Symposium: A Nurse’s Guide to Immune Checkpoint Inhibitors in Combination With Select Other Treatment Modalities
AstraZeneca

8:00 AM - 9:15 AM ET

Breakfast Activity/Non-CE Satellite Symposium: Targeted Therapy in mIDH Adult-Type Diffuse Glioma
Servier Pharmaceuticals

8:15 AM - 9:15 AM ET

Breakfast Activity: Non-CE Satellite Symposium

9:20 AM - 10:20 AM ET

New Drug Updates: Hematologic Malignancies

Speaker: – The Johns Hopkins Hospital

Livestream

CE/CME: 1.00 credits/hours

9:20 AM - 10:20 AM ET

Speaking Volumes: Inclusive Communication Strategies for Cancer Care in Diverse Populations

Speaker: – Memorial Sloan Kettering Cancer Center

CE/CME: 1.00 credits/hours

10:30 AM - 11:15 AM ET

Bridging Worlds: Integrating Herbal Knowledge with Conventional Cancer Care

Speaker: – Memorial Sloan Kettering Cancer Center

CE/CME: 0.75 credits/hours

10:30 AM - 11:15 AM ET

New Frontiers in Neuroendocrine Tumors: Enhancing Diagnosis, Treatment, and Patient Outcomes

Speaker: – Duke Cancer Center

CE/CME: 0.75 credits/hours

11:15 AM - 11:30 AM ET

Refreshment Break

11:20 AM - 12:20 PM ET

Mitigating Risk, Maximizing Care: Legal Literacy in Oncology Practice

Speaker: – UNC Health

Speaker: – Flores Law Firm

Speaker: – Texas Oncology

CE/CME: 1.00 credits/hours

12:20 PM ET

Conference Concludes

12:20 PM - 1:50 PM ET

Independent CE Lunch Satellite Symposium: Antibody–Drug Conjugates in Oncology: The Essentials of AE Management for Better Patient Outcomes